Zions Bancorporation’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $5.82K | Buy |
172
+17
| +11% | +$612 | ﹤0.01% | 685 |
|
|
2024
Q3 | $6.34K | Sell |
155
-128
| -45% | -$5.24K | ﹤0.01% | 678 |
|
|
2024
Q2 | $10.9K | Buy |
283
+42
| +17% | +$1.77K | ﹤0.01% | 651 |
|
|
2024
Q1 | $10.3K | Buy |
241
+13
| +6% | +$536 | ﹤0.01% | 666 |
|
|
2023
Q4 | $8.45K | Buy |
228
+9
| +4% | +$323 | ﹤0.01% | 687 |
|
|
2023
Q3 | $7.94K | Buy |
219
+117
| +115% | +$4.15K | ﹤0.01% | 664 |
|
|
2023
Q2 | $3.63K | Sell |
102
-4
| -4% | -$143 | ﹤0.01% | 769 |
|
|
2023
Q1 | $3.77K | Sell |
106
-177
| -63% | -$6.19K | ﹤0.01% | 762 |
|
|
2022
Q4 | $9.95K | Sell |
283
-102
| -26% | -$3.4K | ﹤0.01% | 723 |
|
|
2022
Q3 | $11K | Sell |
385
-227
| -37% | -$8.6K | ﹤0.01% | 648 |
|
|
2022
Q2 | $33K | Buy |
612
+116
| +23% | +$6.4K | ﹤0.01% | 521 |
|
|
2022
Q1 | $27K | Buy |
496
+80
| +19% | +$4.34K | ﹤0.01% | 622 |
|
|
2021
Q4 | $23K | Hold |
416
| – | – | ﹤0.01% | 597 |
|
|
2021
Q3 | $20K | Sell |
416
-633
| -60% | -$31.8K | ﹤0.01% | 614 |
|
|
2021
Q2 | $52K | Sell |
1,049
-1,017
| -49% | -$48.9K | 0.01% | 425 |
|
|
2021
Q1 | $92K | Sell |
2,066
-16
| -0.8% | -$726 | 0.01% | 349 |
|
|
2020
Q4 | $96K | Sell |
2,082
-31,187
| -94% | -$1.43M | 0.01% | 320 |
|
|
2020
Q3 | $1.56M | Sell |
33,269
-7,269
| -18% | -$364K | 0.22% | 51 |
|
|
2020
Q2 | $2.07M | Sell |
40,538
-972
| -2% | -$49.9K | 0.3% | 37 |
|
|
2020
Q1 | $1.97M | Buy |
41,510
+3,682
| +10% | +$196K | 0.34% | 32 |
|
|
2019
Q4 | $2.22M | Sell |
37,828
-2,853
| -7% | -$159K | 0.32% | 30 |
|
|
2019
Q3 | $2.17M | Buy |
40,681
+1,281
| +3% | +$65.9K | 0.31% | 32 |
|
|
2019
Q2 | $1.97M | Buy |
39,400
+1,822
| +5% | +$91.4K | 0.29% | 30 |
|
|
2019
Q1 | $1.96M | Buy |
37,578
+14,737
| +65% | +$736K | 0.32% | 34 |
|
|
2018
Q4 | $1.09M | Sell |
22,841
-12,736
| -36% | -$627K | 0.8% | 22 |
|
|
2018
Q3 | $1.79M | Buy |
35,577
+1,179
| +3% | +$59.9K | 0.42% | 26 |
|
|
2018
Q2 | $1.73M | Buy |
+34,398
| New | +$1.73M | 1.19% | 14 |
|
|
2017
Q4 | – | Sell |
-24,746
| Closed | -$1.26M | – | 759 |
|
|
2017
Q3 | $1.26M | Buy |
24,746
+23,859
| +2,690% | +$1.21M | 0.18% | 77 |
|
|
2017
Q2 | $48K | Sell |
887
-53
| -6% | -$2.83K | 0.01% | 214 |
|
|
2017
Q1 | $51K | Buy |
940
+68
| +8% | +$3.45K | 0.01% | 197 |
|
|
2016
Q4 | $42K | Sell |
872
-272
| -24% | -$13.4K | 0.01% | 263 |
|
|
2016
Q3 | $61K | Buy |
1,144
+645
| +129% | +$35.4K | 0.01% | 211 |
|
|
2016
Q2 | $27K | Sell |
499
-255
| -34% | -$13.4K | ﹤0.01% | 281 |
|
|
2016
Q1 | $41K | Sell |
754
-19
| -2% | -$946 | 0.01% | 274 |
|
|
2015
Q4 | $39K | Buy |
773
+78
| +11% | +$3.98K | 0.01% | 243 |
|
|
2015
Q3 | $36K | Buy |
+695
| New | +$36.2K | 0.01% | 259 |
|
|
2015
Q2 | – | Sell |
-1,134
| Closed | -$66K | – | 455 |
|
|
2015
Q1 | $66K | Buy |
+1,134
| New | +$65K | 0.01% | 194 |
|
Other funds holding GSK
JEST
Zions Bancorporation's GSK Position: Q4 2024 in Review
Zions Bancorporation increased its GSK (GSK) stake by 11% in Q4 2024, buying an estimated $612 and bringing the position to 172 shares worth $5.82K. The position accounts for ﹤0.01% of the portfolio, ranked #685.
Zions Bancorporation first reported a position in GSK in Q1 2015 and has held it in 37 quarters since. The position peaked at $2.22M in Q4 2019. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.
- Zions Bancorporation held 172 shares of GSK worth $5.82K as of Q4 2024.
- Zions Bancorporation bought 17 GSK shares in Q4 2024, an estimated $612.
- GSK made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #685 holding.
- Zions Bancorporation first reported a position in GSK in Q1 2015 and has held it in 37 quarters since.
- Zions Bancorporation's GSK position peaked at $2.22M in Q4 2019.
- 849 funds tracked by Wall St. Rank held GSK as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.